{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.138G>K",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "K",
            "position": "138"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "46"
          },
          "Description in input context": "E46K mutation increases the propensity of -synuclein to fibrillize."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005597"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot, SDS-PAGE, and electron microscopy",
      "Material used": {
        "Material Source": " Cell line (SH-SY5Y), Protein",
        "Material Name": "human recombinant -synuclein",
        "Description": "Protein was expressed in E. coli or SH-SY5Y cells and purified using standard protocols."
      },
      "Readout type": "Quantitative, Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.138G>K",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Electron microscopy revealed the presence of amyloid fibrils, and Western Blot showed increased protein levels."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed using SH-SY5Y cells."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate using SDS-PAGE and Western Blot."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type -synuclein protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or water was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}